Tubulin microtentacles in detached mammary epithelial cells
Tubulin microtentacles in detached mammary epithelial cells
批准号:
9767675
负责人:
STUART S MARTIN
金额:
$43.66万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-01 至 2021-08-31
关键词:
ActinsAffectAnimalsAntineoplastic AgentsBlood VesselsBlood capillariesBreast Cancer CellBreast Cancer PatientBreast Epithelial CellsCarcinomaCell divisionCell membraneCellsCharacteristicsChemicalsCytoskeletonDataDevelopmentDistantEMS1 geneElectron MicroscopyEndothelial CellsEndotheliumEpithelial CellsExtracellular MatrixFutureGenerationsGeneticGoalsHourHumanImageIncidenceInvadedKnowledgeLeadLipidsLung retentionMalignant Epithelial CellMammary NeoplasmsMammospheresMediatingMicrotubule StabilizationMicrotubulesMolecularMolecular TargetMutationMyosin ATPaseNeoadjuvant TherapyNeoplasm Circulating CellsNeoplasm MetastasisOperative Surgical ProceduresPTEN genePTEN proteinPaclitaxelPatientsPharmaceutical PreparationsPhosphoric Monoester HydrolasesPhosphorylationPublishingRecurrenceRegulationResearchResolutionRiskRoleSignal TransductionSolid NeoplasmSpeedStem cellsStructureSurfaceTailTestingTherapeuticTherapeutic InterventionTissuesTubulinTumor Suppressor ProteinsVeinsWorkXenograft procedureanticancer researchbasecancer recurrencecancer riskcancer therapycell growthcell motilitychemotherapycofilincomparativedrug developmentepithelial to mesenchymal transitionimprovedinhibitor/antagonistinterestmalignant breast neoplasmneoplastic cellnew therapeutic targetnovelpressureprotein biomarkerspublic health relevanceresponserestorationrestraintrhosrc-Family Kinasessuccesstherapeutic targettumortumor growthwhole animal imaging
中文摘要
描述(由申请人提供):已知细胞骨架改变会影响循环肿瘤细胞(CTCs)的转移成功。然而,对肿瘤细胞骨架的研究几乎完全集中在附着在细胞表面或细胞外基质上的细胞,留下了与转移相关的显著知识缺口。PI的研究小组最近的工作表明,循环中的肿瘤细胞的细胞骨架与附着在细胞外基质上的细胞的反应非常不同。具体地说,自由漂浮的肿瘤细胞产生独特的
基于微管蛋白的微触手(McTns),促进CTCs重新附着到内皮细胞层。活体动物的成像显示,CTCs通过与McTns匹配的细胞骨架机制重新附着在血管壁上。来自PI实验室的新数据现在表明,在手术期间从乳腺癌患者身上分离出来的肿瘤细胞中,可以在几个小时内检测到McTns。此外,患者的肿瘤细胞药物反应可以在几分钟内进行测量。由于McTns是由微管蛋白支持的,常见的乳腺癌药物紫杉醇(紫杉醇)实际上增强了McTns并加速了肿瘤细胞的再附着。开发旨在通过靶向肌动蛋白细胞骨架来抑制附着的肿瘤细胞运动的抗癌药物也能增强McTns。这些结果强调了确定针对细胞分裂或附着的肿瘤细胞的运动的抗癌药物是否会无意中增加转移的重要性。由于手术和新辅助化疗都能显著提高CTCs的水平,因此了解哪些分子靶点会降低CTCs的转移效率以及哪些分子靶点可能会增加转移风险是很重要的。近90%的人类实体瘤起源于上皮细胞,其大小和僵硬往往导致其在狭窄的毛细血管中碎裂。这种对转移效率的抑制可能会对循环中的癌细胞施加选择性压力,使其发展出重新附着于血管壁和逃避碎裂的机制。PI实验室最近的工作发现,当质膜下的肌动蛋白皮质受到遗传改变或化学处理的破坏时,McTN会增加。这项研究将检验这样一种假设,即遗传或治疗性肌动蛋白皮质的失调诱导微管蛋白McTns,从而促进循环中肿瘤细胞的转移再附着。这一假说的预测将在以下特定的人工智能中得到验证:1)确定PTEN缺失促进McTns的分子机制。2)明确Src信号在McTN延伸和肿瘤转移中的作用。3)研究靶向Rho/ROCK介导的肌动蛋白收缩作用对McTN生成的影响。该项目的长期目标是确定控制肌动蛋白破坏以促进循环肿瘤细胞中McTns的分子机制。扩大我们对McTN结构和分子调控的理解,以及检测McTN在人类乳腺癌患者来源的肿瘤细胞中的发病率和功能,将既可以识别新的治疗靶点,又可以揭示当前癌症药物的潜在转移风险。
英文摘要
DESCRIPTION (provided by applicant): Cytoskeletal alterations are known to influence the metastatic success of circulating tumor cells (CTCs). However, studies of the tumor cell cytoskeleton are almost exclusively focused on cells attached to surfaces or extracellular matrix leaving a significant knowledge gap relevant to metastasis. Recent work from the PI's research group has demonstrated that the cytoskeleton of circulating tumor cells responds very differently from cells attached to extracellular matrix. Specifically, free-floating tumor cells produce unique
tubulin-based microtentacles (McTNs) that promote the reattachment of CTCs to endothelial cell layers. Imaging in live animals has shown that CTCs reattach to blood vessel walls via a cytoskeletal mechanism that matches McTNs. New data from the PI's lab now demonstrate that McTNs are detectable in tumor cells within hours of their isolation from breast cancer patients during surgery. Moreover, patient tumor cell drug responses can be gauged within minutes. Since McTNs are supported by tubulin, the common breast cancer drug, Paclitaxel (Taxol), actually strengthens McTNs and speeds tumor cell reattachment. Developing cancer drugs aimed at inhibiting attached tumor cell motility by targeting the actin cytoskeleton also enhance McTNs. These results emphasize the importance of determining whether cancer drugs aimed at cell division or the motility of attached tumor cells could inadvertently increase metastasis. Sinc both surgery and neoadjuvant chemotherapy can strongly increase the levels of CTCs, it is important to understand which molecular targets will reduce the metastatic efficiency of CTCs and which may increase metastatic risk. Nearly 90% of human solid tumors arise as carcinomas from epithelial cells, whose large size and rigidity often lead to their fragmentation in narrow capillaries. This restraint on metastatic efficiency could impose a selective pressure for circulating carcinoma cells to develop mechanisms to reattach to blood vessel walls and escape fragmentation. Recent work in the PI's lab has identified that McTNs are increased when the actin cortex beneath the plasma membrane is disrupted via either genetic alterations or chemical treatments. This study will test the hypothesis that genetic or therapeutic dysregulation of the actin cortex induces tubulin McTNs that promote the metastatic reattachment of circulating tumor cells. Predictions of this hypothesis will be tested in the following specific ais: 1) Define the molecular mechanism by which PTEN loss promotes McTNs. 2) Identify the role of Src signaling in McTN extension and tumor metastasis. 3) Examine the role of targeting Rho/ROCK mediated actin contractility on McTN generation. The long-term goals of this project are to define the molecular mechanisms that govern actin disruption to promote McTNs in circulating tumor cells. Extending our understanding of McTN structure and molecular regulation as well as examining McTN incidence and function in tumor cells derived from human breast cancer patients will both identify novel therapeutic targets and reveal potential metastatic risks of current cancer drugs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk
-
批准号:9563061
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:STUART S MARTIN
-
依托单位:
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk
-
批准号:10413064
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:STUART S MARTIN
-
依托单位:
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk
-
批准号:10663790
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:STUART S MARTIN
-
依托单位:
Rapid analysis of patient tumor cell drug responses to reduce metastatic risk
-
批准号:10045933
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:STUART S MARTIN
-
依托单位:
Targeting microtubule stabilization to reduce breast tumor metastasis
-
批准号:8540982
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2012
-
负责人:STUART S MARTIN
-
依托单位:
Targeting microtubule stabilization to reduce breast tumor metastasis
-
批准号:8688930
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2012
-
负责人:STUART S MARTIN
-
依托单位:
Targeting microtubule stabilization to reduce breast tumor metastasis
-
批准号:9089934
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2012
-
负责人:STUART S MARTIN
-
依托单位:
Targeting microtubule stabilization to reduce breast tumor metastasis
-
批准号:10212975
-
项目类别:
-
资助金额:$36.69万
-
财政年份:2012
-
负责人:STUART S MARTIN
-
依托单位:
Targeting microtubule stabilization to reduce breast tumor metastasis
-
批准号:10437846
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2012
-
负责人:STUART S MARTIN
-
依托单位:
Targeting microtubule stabilization to reduce breast tumor metastasis
-
批准号:10660995
-
项目类别:
-
资助金额:$35.96万
-
财政年份:2012
-
负责人:STUART S MARTIN
-
依托单位:
Hormone Related Cancers Program
-
批准号:10267042
-
项目类别:
-
资助金额:$3.96万
-
财政年份:2008
-
负责人:STUART S MARTIN
-
依托单位:
Tubulin microtentacles in detached mammary epithelial cells
-
批准号:10697349
-
项目类别:
-
资助金额:$42.4万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
Tubulin microtentacles in detached mammary epithelial cells
-
批准号:10298137
-
项目类别:
-
资助金额:$43.76万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
Single cell determination of ROS and calcium roles in breast cancer apoptotic resistance
-
批准号:10817296
-
项目类别:
-
资助金额:$8.48万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
Tubulin microtentacles in detached mammary epithelial cells
-
批准号:9756676
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
Stabilized microtubule protrusions in detached mammary epithelial cells
-
批准号:7812078
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
Stabilized microtubule protrusions in detached mammary epithelial cells
-
批准号:7395002
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
Tubulin microtentacles in detached mammary epithelial cells
-
批准号:8888360
-
项目类别:
-
资助金额:$29.56万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
Stabilized microtubule protrusions in detached mammary epithelial cells
-
批准号:7640901
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
Stabilized microtubule protrusions in detached mammary epithelial cells
-
批准号:7183253
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2007
-
负责人:STUART S MARTIN
-
依托单位:
海外基金